Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Introduction: The EPaNIC randomized controlled multicentre trial showed that postponing initiation of parenteral nutrition (PN) in ICU-patients to beyond the first week (Late-PN) enhanced recovery, as compared with Early-PN. This was mediated by fewer infections, accelerated recovery from organ failure and reduced duration of hospitalization. Now, the trial's preplanned cost analysis (N = 4640) from the Belgian healthcare payers' perspective is reported. Methods: Cost data were retrieved from individual patient invoices. Undiscounted total healthcare costs were calculated for the index hospital stay. A cost tree based on acquisition of new infections and on prolonged length-of-stay was constructed. Contribution of 8 cost categories to total hospitalization costs was analyzed. The origin of drug costs was clarified in detail through the Anatomical Therapeutic Chemical (ATC) classification system. The potential impact of Early-PN on total hospitalization costs in other healthcare systems was explored in a sensitivity analysis. Results: ICU-patients developing new infection (24.4%) were responsible for 42.7% of total costs, while ICU-patients staying beyond one week (24.3%) accounted for 43.3% of total costs. Pharmacy-related costs represented 30% of total hospitalization costs and were increased by Early-PN (+608.00 EUR/patient, p = 0.01). Notably, costs for ATC-J (anti-infective agents) (+227.00 EUR/patient, p = 0.02) and ATC-B (comprising PN) (+220.00 EUR/patient, p = 0.006) drugs were increased by Early-PN. Sensitivity analysis revealed a mean total cost increase of 1,210.00 EUR/patient (p = 0.02) by Early-PN, when incorporating the full PN costs. Conclusions: The increased costs by Early-PN were mainly pharmacy-related and explained by higher expenditures for PN and anti-infective agents. The use of Early-PN in critically ill patients can thus not be recommended for both clinical (no benefit) and cost-related reasons. Trial registration: ClinicalTrials.gov NCT00512122 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Early versus late parenteral nutrition in critically ill adults
Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102662 · Cited by 1,696
Self-citationHow should cost data in pragmatic randomised trials be analysed?
Thompson, S. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1197 · Cited by 772 · cited 1×
“The costs in the two treatment groups were analyzed with the Student t test, and the costs between periods 1 and 2 were analyzed with the paired t test [12,20].”
MethodCommon methodological flaws in economic evaluations
Drummond, M., & Sculpher, M. (2005) · Medical Care · doi:10.1097/01.mlr.0000170001.10393.b7 · Cited by 204
Parenteral with enteral nutrition in the critically ill
Bauer, P., Charpentier, C., Bouchet, C., Nace, L., Raffy, F., & Gaconnet, N. (2000) · Intensive Care Medicine · doi:10.1007/s001340051278 · Cited by 169 · cited 1×
“Previous non-conclusive trials investigating clinical effects of parenteral nutrition (PN) supplementing enteral nutrition (EN) in critically ill patients were small [1], and studies analyzing the resource use or costs associated with such nutritional strategies are scarce [2].”
BackgroundWilkinson, L. (2006) · The American Statistician · doi:10.1198/000313006x152243 · Cited by 134 · cited 1×
“A Pareto chart visualized the contribution of each category to total health-care costs [18].”
Background
Cited by
Hermans, G., Van Mechelen, H., Clerckx, B., Vanhullebusch, T., Mesotten, D., Wilmer, A., Casaer, M. P., Meersseman, P., Debaveye, Y., Van Cromphaut, S., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2257oc · Cited by 533
Self-citationNutrition in the acute phase of critical illness
Casaer, M. P., & Van den Berghe, G. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1304623 · Cited by 335
Self-citationRole of Disease and Macronutrient Dose in the Randomized Controlled EPaNIC Trial
Casaer, M. P., Wilmer, A., Hermans, G., Wouters, P. J., Mesotten, D., & Van den Berghe, G. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-0999oc · Cited by 307
Self-citationMerker, M., Felder, M., Gueissaz, L., Bolliger, R., Tribolet, P., Kägi-Braun, N., Gomes, F., Hoess, C., Pavlicek, V., Bilz, S., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.0663 · Cited by 262
Charles, E. J., Petroze, R. T., Metzger, R., Hranjec, T., Rosenberger, L. H., Riccio, L. M., McLeod, M. D., Guidry, C. A., Stukenborg, G. J., Swenson, B. R., et al. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.088609 · Cited by 122
Metadata
- Authors
- Vanderheyden, S., Casaer, M. P., Kesteloot, K., Simoens, S., De Rijdt, T., Peers, G., Wouters, P. J., Coenegrachts, J., Grieten, T., Polders, K., Maes, A., Wilmer, A., Dubois, J., Van den Berghe, G., & Mesotten, D.
- Venue
- Critical Care
- Published
- 2012-05-25
- Volume
- 16
- Issue
- 3
- Pages
- R96-R96
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2100566529
- Cited by
- 70
- References
- 6
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial. https://app.cochat.ai/papers/10.1186/cc11361
- The paper
- Vanderheyden, S., Casaer, M. P., Kesteloot, K., Simoens, S., De Rijdt, T., Peers, G., Wouters, P. J., Coenegrachts, J., Grieten, T., Polders, K., Maes, A., Wilmer, A., Dubois, J., Van den Berghe, G., & Mesotten, D. (2012). Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial. Critical Care. https://doi.org/10.1186/cc11361
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.